Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2017 February;83(2) > Minerva Anestesiologica 2017 February;83(2):138-44

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

 

ORIGINAL ARTICLE   Freefree

Minerva Anestesiologica 2017 February;83(2):138-44

DOI: 10.23736/S0375-9393.16.11349-5

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Comparison of three different doses sugammadex based on ideal body weight for reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery

Ahmad M. ABD EL-RAHMAN 1, Ahmed H. OTHMAN 1, Fatma A. EL SHERIF 1, Mohamed F. MOSTAFA 2, Osama TAHA 3

1 Department of Anesthesia, ICU and Pain Relief, South Egypt Cancer Institute, Assiut University, Assiut, Egypt; 2 Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt; 3 Department of Plastic Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt


PDF


BACKGROUND: The majority of authors and the literature recommend sugammadex dose to be calculated according to RBW without taking fat content into consideration. Our aim was to compare the efficacy and safety of sugammadex at doses of 1.5, 2, and 4 mg/kg, calculated according to ideal body weight basis, for the reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.
METHODS: One-hundred and eighty morbidly obese patients were randomly assigned into three groups according to sugammadex dose administrated (based on IBW after reaching T2 of TOF): Group I: patients were given 1.5 mg/kg. Group II: patients were given 2 mg/kg. Group III: patients were given 4 mg/kg. Both sugammadex and extubation times were recorded.
RESULTS: Sugammadex time was significantly longer in groups I and II versus III (P=0.000, 0.005 respectively). Difference between groups I and II was insignificant. The extubation time was insignificantly different in the three groups (P>0.05).
CONCLUSIONS: A dose of sugammadex of 1.5 mg/kg calculated according to IBW successfully reversed moderate rocuronium-induced NMB in laparoscopic bariatric surgeries.


KEY WORDS: Neuromuscular blockade - Rocuronium - Sugammadex - Bariatric surgery - Laparoscopy - Ideal body weight

inizio pagina